Archive: 22/10/2018
Immunotherapy effective as first-line treatment for advanced head and neck cancer
Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.
Oct 22, 2018